ENDRA Life Sciences (NDRA) Depreciation & Amortization (CF) (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Depreciation & Amortization (CF) of $9492.0 for Q1 2026, down 31.15% year-over-year from $13786.0 in Q1 2025, and down 6.18% quarter-over-quarter from $10117.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $9492.0 in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $9492.0, down 31.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $39751.0 (down 11.62% YoY), and the FY2025 annual result was $44045.0, down 5.26% from the prior year.
- Depreciation & Amortization (CF) retreated to $9492.0 in Q1 2026 per NDRA's latest filing, from $10117.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $35265.0 in Q2 2023 and troughed at $8693.0 in Q2 2024.
- A 5-year average of $18847.8 and a median of $15300.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) soared 81.3% in 2023, then slumped 75.35% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $32129.0 in 2022, then tumbled by 31.88% to $21887.0 in 2023, then slumped by 49.74% to $11000.0 in 2024, then dropped by 8.03% to $10117.0 in 2025, then fell by 6.18% to $9492.0 in 2026.
- Business Quant data shows NDRA's Depreciation & Amortization (CF) at $9492.0 in Q1 2026, $10117.0 in Q4 2025, and $10786.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 36.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 306.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 193.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 37.68 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 67.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 14.52 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 288.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 51.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 13.16 Mn |
| 10 | ENDRA Life Sciences | 5.24 Mn | 4.89 Mn | - | 9,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,492.00 |
| Mar 31, 2026 | 9,492.00 |
| Dec 31, 2025 | 10,117.00 |
| Dec 31, 2025 | 10,117.00 |
| Sep 30, 2025 | 10,786.00 |
| Sep 30, 2025 | 10,786.00 |
| Jun 30, 2025 | 9,356.00 |
| Jun 30, 2025 | 9,356.00 |
| Mar 31, 2025 | 13,786.00 |
| Mar 31, 2025 | 13,786.00 |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,496.00 |
| Sep 30, 2024 | 11,496.00 |
| Jun 30, 2024 | 8,693.00 |
| Jun 30, 2024 | 8,693.00 |
| Mar 31, 2024 | 15,300.00 |
| Mar 31, 2024 | 15,300.00 |
| Dec 31, 2023 | 21,887.00 |
| Dec 31, 2023 | 21,887.00 |